Detalles de la búsqueda
1.
Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study.
Leukemia
; 34(8): 2064-2073, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32265500
2.
Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine.
J Clin Oncol
; 28(25): 3922-8, 2010 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20679609
Resultados
1 -
2
de 2
1
Próxima >
>>